IMIC(SZ:000516) Sou Hu Cai Jing·2025-09-10 13:17Core Viewpoint - International Medical (000516) shows mixed financial performance with a decline in revenue and negative net profit, while experiencing some positive trends in net profit growth in recent quarters [2][3] Financial Performance - As of September 10, 2025, the stock price is 5.12 CNY, with a slight increase of 0.2% and a trading volume of 169,900 shares, totaling a transaction value of 86.90 million CNY [1] - The company reported a total revenue of 2.034 billion CNY for the first half of 2025, a year-on-year decrease of 15.95%, while the net profit attributable to shareholders was -165 million CNY, an increase of 4.98% year-on-year [2] - The second quarter of 2025 saw a revenue of 1.037 billion CNY, down 16.86% year-on-year, with a net profit of -58.61 million CNY, up 14.68% year-on-year [2] Market Position - The total market capitalization of International Medical is 11.463 billion CNY, ranking 12th in the medical services industry, which has an average market cap of 21.252 billion CNY [2] - The company has a negative return on equity (ROE) of -4.6%, ranking 39th in the industry, where the average ROE is 2.19% [2] Key Ratios - The price-to-earnings (P/E) ratio is -34.74, significantly lower than the industry average of 83.8 [2] - The gross margin stands at 7.8%, compared to the industry average of 35.92%, indicating a weaker profitability position [2] Investment Sentiment - In the last 90 days, one institution has given a buy rating for the stock, indicating some level of positive sentiment among analysts [3]